Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
NEKTAR THERAPEUTICS (NKTR)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
20 Feb 2024
Wilson Mark Andrew
Chief Legal Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
236,674
-3%
7,606
$0.68
$5,172.08
SELL
20 Feb 2024
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
879,889
-2%
20,033
$0.68
$13,622.44
SELL
20 Feb 2024
Zalevsky Jonathan
Chief R&D Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
265,025
-3%
9,014
$0.68
$6,129.52
SELL
18 Sep 2023
Ajer Jeffrey Robert
Director
NEKTAR THERAPEUTICS
(NKTR)
34,153
-11%
4,359
$0.69
$3,007.71
SELL
18 Sep 2023
CHESS ROBERT
Director
NEKTAR THERAPEUTICS
(NKTR)
274,773
-3%
10,200
$0.67
$6,834.00
SELL
18 Sep 2023
Curet Myriam
Director
NEKTAR THERAPEUTICS
(NKTR)
27,418
-13%
4,359
$0.69
$3,007.71
SELL
16 Aug 2023
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
919,799
-2%
19,998
$0.78
$15,598.44
SELL
16 Aug 2023
Zalevsky Jonathan
Chief R&D Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
283,685
-3%
9,703
$0.78
$7,568.34
SELL
16 Aug 2023
Wilson Mark Andrew
Chief Legal Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
250,959
-2%
7,221
$0.78
$5,632.38
SELL
14 Jun 2023
WHITFIELD ROY A
Director
NEKTAR THERAPEUTICS
(NKTR)
216,250
-12%
30,000
$0.57
$17,100.00
SELL
16 May 2023
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
939,797
-2%
20,361
$0.72
$14,659.92
SELL
16 May 2023
Wilson Mark Andrew
Chief Legal Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
257,680
-2%
7,543
$0.72
$5,430.96
SELL
16 May 2023
Zalevsky Jonathan
Chief R&D Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
293,388
-3%
9,791
$0.72
$7,049.52
SELL
16 Feb 2023
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
960,158
-2%
19,635
$3.00
$58,905.00
SELL
16 Feb 2023
Wilson Mark Andrew
Chief Legal Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
265,223
-3%
8,275
$3.00
$24,825.00
SELL
16 Feb 2023
Thomsen Jillian B.
Chief Financial Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
313,497
-3%
10,267
$3.00
$30,801.00
SELL
16 Feb 2023
Zalevsky Jonathan
Chief R&D Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
303,179
-3%
10,484
$3.00
$31,452.00
SELL
16 Nov 2022
Wilson Mark Andrew
Chief Legal Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
272,498
-3%
8,690
$3.57
$31,023.30
SELL
16 Nov 2022
Thomsen Jillian B.
Chief Financial Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
323,764
-3%
11,095
$3.57
$39,609.15
SELL
16 Nov 2022
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
979,793
-3%
38,014
$3.57
$135,709.98
SELL
16 Nov 2022
Zalevsky Jonathan
Chief R&D Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
313,663
-4%
13,460
$3.57
$48,052.20
SELL
23 Sep 2022
Curet Myriam
Director
NEKTAR THERAPEUTICS
(NKTR)
31,777
-11%
4,198
$3.16
$13,265.68
SELL
23 Sep 2022
Ajer Jeffrey Robert
Director
NEKTAR THERAPEUTICS
(NKTR)
38,512
-9%
4,198
$3.16
$13,265.68
SELL
22 Sep 2022
CHESS ROBERT
Director
NEKTAR THERAPEUTICS
(NKTR)
228,179
-2%
5,100
$3.19
$16,269.00
SELL
13 Sep 2022
EASTHAM KARIN
Director
NEKTAR THERAPEUTICS
(NKTR)
13,033
-62%
21,267
$3.61
$76,773.87
SELL
18 Aug 2022
Zalevsky Jonathan
Chief R&D Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
327,123
-18%
73,716
$4.65
$342,779.40
SELL
15 Aug 2022
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
1,017,807
-1%
13,759
$4.76
$65,492.84
SELL
15 Aug 2022
Zalevsky Jonathan
Chief R&D Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
400,839
-2%
10,560
$4.76
$50,265.60
SELL
15 Aug 2022
Wilson Mark Andrew
SVP & General Counsel, Officer
NEKTAR THERAPEUTICS
(NKTR)
281,188
-1%
3,189
$4.76
$15,179.64
SELL
15 Aug 2022
Thomsen Jillian B.
SVP & Chief Accounting Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
334,859
-0%
2,006
$4.76
$9,548.56
SELL
16 May 2022
Wilson Mark Andrew
SVP & General Counsel, Officer
NEKTAR THERAPEUTICS
(NKTR)
117,939
-2%
3,136
$3.95
$12,387.20
SELL
16 May 2022
NORTHCOTT JOHN
SVP & Chief Commercial Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
223,210
-2%
4,592
$3.95
$18,138.40
SELL
15 May 2022
Labrucherie Gil M
SVP, COO & CFO, Officer
NEKTAR THERAPEUTICS
(NKTR)
312,905
-5%
17,448
$3.95
$68,919.60
SELL
15 May 2022
Thomsen Jillian B.
SVP & Chief Accounting Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
170,427
-3%
5,841
$3.95
$23,071.95
SELL
15 May 2022
Zalevsky Jonathan
Chief R&D Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
276,399
-7%
21,673
$3.95
$85,608.35
SELL
15 May 2022
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
620,941
-5%
36,529
$3.95
$144,289.55
SELL
16 Feb 2022
Wilson Mark Andrew
SVP & General Counsel, Officer
NEKTAR THERAPEUTICS
(NKTR)
121,075
-2%
3,661
$10.95
$40,087.95
SELL
16 Feb 2022
NORTHCOTT JOHN
SVP & Chief Commercial Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
227,802
-2%
4,852
$10.95
$53,129.40
SELL
16 Feb 2022
Labrucherie Gil M
SVP, COO & CFO, Officer
NEKTAR THERAPEUTICS
(NKTR)
301,603
-2%
7,579
$10.95
$82,990.05
SELL
16 Feb 2022
Thomsen Jillian B.
SVP & Chief Accounting Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
165,318
-1%
2,363
$10.95
$25,874.85
SELL
16 Feb 2022
Zalevsky Jonathan
Chief R&D Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
274,122
-3%
10,912
$10.95
$119,486.40
SELL
16 Feb 2022
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
589,020
-2%
12,480
$10.95
$136,656.00
SELL
16 Nov 2021
NORTHCOTT JOHN
SVP & Chief Commercial Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
194,854
-3%
6,061
$13.16
$79,762.76
SELL
16 Nov 2021
Labrucherie Gil M
SVP, COO & CFO, Officer
NEKTAR THERAPEUTICS
(NKTR)
256,682
-8%
24,149
$13.10
$316,390.84
SELL
15 Nov 2021
Wilson Mark Andrew
SVP & General Counsel, Officer
NEKTAR THERAPEUTICS
(NKTR)
86,436
-7%
6,564
$13.16
$86,382.24
SELL
15 Nov 2021
Thomsen Jillian B.
SVP & Chief Accounting Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
145,981
-4%
6,741
$13.16
$88,711.56
SELL
15 Nov 2021
Zalevsky Jonathan
Chief R&D Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
232,084
-8%
20,869
$13.16
$274,636.03
SELL
15 Nov 2021
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
475,450
-8%
42,773
$13.16
$562,892.70
SELL
22 Sep 2021
Ajer Jeffrey Robert
Director
NEKTAR THERAPEUTICS
(NKTR)
32,510
-10%
3,665
$17.78
$65,163.70
SELL
22 Sep 2021
CHESS ROBERT
Director
NEKTAR THERAPEUTICS
(NKTR)
279,873
-1%
4,600
$17.94
$82,524.00
SELL
22 Sep 2021
Curet Myriam
Director
NEKTAR THERAPEUTICS
(NKTR)
25,775
-12%
3,665
$17.78
$65,163.70
SELL
8 Sep 2021
CHESS ROBERT
Director
NEKTAR THERAPEUTICS
(NKTR)
274,273
-6%
18,279
$16.01
$292,669.56
SELL
16 Aug 2021
Wilson Mark Andrew
SVP & General Counsel, Officer
NEKTAR THERAPEUTICS
(NKTR)
72,900
-2%
1,910
$13.83
$26,415.30
SELL
16 Aug 2021
NORTHCOTT JOHN
SVP & Chief Commercial Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
200,915
-2%
6,192
$13.83
$85,635.36
SELL
16 Aug 2021
Labrucherie Gil M
SVP, COO & CFO, Officer
NEKTAR THERAPEUTICS
(NKTR)
240,231
-4%
10,867
$13.76
$149,480.61
SELL
16 Aug 2021
Thomsen Jillian B.
SVP & Chief Accounting Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
137,822
-8%
13,339
$13.83
$184,478.38
SELL
16 Aug 2021
Zalevsky Jonathan
Chief R&D Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
212,803
-3%
7,662
$13.83
$105,965.46
SELL
16 Aug 2021
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
424,123
-2%
11,515
$13.83
$159,252.45
SELL
20 Jul 2021
CHESS ROBERT
Director
NEKTAR THERAPEUTICS
(NKTR)
280,573
-1%
5,721
$16.81
$96,148.03
SELL
17 May 2021
Wilson Mark Andrew
SVP & General Counsel, Officer
NEKTAR THERAPEUTICS
(NKTR)
74,810
-2%
1,917
$18.30
$35,081.10
SELL
17 May 2021
NORTHCOTT JOHN
SVP & Chief Commercial Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
207,107
-2%
6,085
$18.30
$111,355.49
SELL
17 May 2021
Labrucherie Gil M
SVP, COO & CFO, Officer
NEKTAR THERAPEUTICS
(NKTR)
251,098
-3%
7,898
$18.30
$144,533.39
SELL
17 May 2021
Thomsen Jillian B.
SVP & Chief Accounting Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
151,161
-8%
13,391
$18.30
$245,055.30
SELL
17 May 2021
Zalevsky Jonathan
Chief R&D Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
235,065
-11%
31,111
$18.30
$569,331.25
SELL
17 May 2021
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
435,638
-2%
11,560
$18.30
$211,547.98
SELL
12 May 2021
CHESS ROBERT
Director
NEKTAR THERAPEUTICS
(NKTR)
280,573
-2%
8,000
$19.34
$154,720.00
SELL
14 Apr 2021
CHESS ROBERT
Director
NEKTAR THERAPEUTICS
(NKTR)
280,573
-2%
8,000
$18.98
$151,840.00
SELL
16 Feb 2021
Wilson Mark Andrew
SVP & General Counsel, Officer
NEKTAR THERAPEUTICS
(NKTR)
76,727
-2%
2,173
$22.37
$48,610.01
SELL
16 Feb 2021
NORTHCOTT JOHN
SVP & Chief Commercial Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
213,192
-6%
15,358
$22.37
$343,558.47
SELL
16 Feb 2021
Labrucherie Gil M
SVP, COO & CFO, Officer
NEKTAR THERAPEUTICS
(NKTR)
258,996
-2%
7,977
$22.37
$178,445.50
SELL
16 Feb 2021
Thomsen Jillian B.
SVP & Chief Accounting Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
164,552
-6%
11,705
$22.37
$261,840.86
SELL
16 Feb 2021
Zalevsky Jonathan
Chief R&D Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
266,176
-8%
24,141
$22.37
$540,034.20
SELL
16 Feb 2021
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
447,198
-2%
11,495
$22.37
$257,143.16
SELL
3 Feb 2021
Wilson Mark Andrew
SVP & General Counsel, Officer
NEKTAR THERAPEUTICS
(NKTR)
78,900
-6%
5,344
$19.45
$103,940.81
SELL
2 Feb 2021
Labrucherie Gil M
SVP, COO & CFO, Officer
NEKTAR THERAPEUTICS
(NKTR)
266,973
-35%
150,000
$19.86
$2,979,629.50
SELL
2 Feb 2021
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
516,830
-46%
450,000
$19.93
$8,966,931.00
SELL
28 Jan 2021
Thomsen Jillian B.
SVP & Chief Accounting Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
176,257
-29%
75,000
$18.62
$1,396,500.10
SELL
15 Dec 2020
Myriam Curet
Director
NEKTAR THERAPEUTICS
(NKTR)
19,240
-7%
1,560
$17.82
$27,799.20
SELL
23 Nov 2020
Zalevsky Jonathan
Chief R&D Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
250,317
-6%
16,380
$16.40
$268,632.00
SELL
16 Nov 2020
Wilson Mark Andrew
SVP & General Counsel, Officer
NEKTAR THERAPEUTICS
(NKTR)
49,850
-2%
1,539
$16.93
$26,055.27
SELL
16 Nov 2020
Labrucherie Gil M
SVP, COO & CFO, Officer
NEKTAR THERAPEUTICS
(NKTR)
226,973
-3%
8,276
$16.93
$140,112.69
SELL
16 Nov 2020
Thomsen Jillian B.
SVP & Chief Accounting Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
159,757
-6%
11,976
$16.93
$202,753.69
SELL
16 Nov 2020
Zalevsky Jonathan
Chief R&D Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
266,697
-9%
29,618
$16.93
$501,432.75
SELL
16 Nov 2020
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
352,043
-3%
11,975
$16.93
$202,736.75
SELL
28 Sep 2020
Ajer Jeffrey Robert
Director
NEKTAR THERAPEUTICS
(NKTR)
25,975
-11%
3,250
$17.25
$56,062.50
SELL
25 Sep 2020
CHESS ROBERT
Director
NEKTAR THERAPEUTICS
(NKTR)
280,573
-1%
5,500
$17.75
$97,625.00
SELL
21 Sep 2020
Ajer Jeffrey Robert
Director
NEKTAR THERAPEUTICS
(NKTR)
20,125
-10%
2,250
$19.74
$44,415.00
SELL
17 Sep 2020
Labrucherie Gil M
SVP, COO & CFO, Officer
NEKTAR THERAPEUTICS
(NKTR)
235,249
-0%
2,000
$19.96
$39,920.00
SELL
8 Sep 2020
CHESS ROBERT
Director
NEKTAR THERAPEUTICS
(NKTR)
276,973
-2%
8,000
$18.53
$148,240.00
SELL
17 Aug 2020
Wilson Mark Andrew
SVP & General Counsel, Officer
NEKTAR THERAPEUTICS
(NKTR)
51,389
-2%
1,529
$19.67
$30,075.43
SELL
17 Aug 2020
Labrucherie Gil M
SVP, COO & CFO, Officer
NEKTAR THERAPEUTICS
(NKTR)
237,249
-3%
8,245
$19.67
$162,199.16
SELL
17 Aug 2020
Thomsen Jillian B.
SVP & Chief Accounting Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
171,733
-0%
1,367
$19.67
$26,888.89
SELL
17 Aug 2020
Zalevsky Jonathan
Chief R&D Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
296,315
-8%
26,200
$19.67
$515,354.00
SELL
17 Aug 2020
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
364,018
-3%
11,885
$19.67
$233,777.95
SELL
9 Jul 2020
GREER R SCOTT
Director
NEKTAR THERAPEUTICS
(NKTR)
176,574
-7%
15,009
$25.00
$375,225.00
SELL
8 Jul 2020
CHESS ROBERT
Director
NEKTAR THERAPEUTICS
(NKTR)
276,973
-2%
8,000
$24.58
$196,640.00
SELL
18 May 2020
Wilson Mark Andrew
SVP & General Counsel, Officer
NEKTAR THERAPEUTICS
(NKTR)
52,418
-2%
1,529
$22.51
$34,417.79
SELL
18 May 2020
Labrucherie Gil M
SVP, COO & CFO, Officer
NEKTAR THERAPEUTICS
(NKTR)
245,494
-3%
7,727
$22.54
$174,154.78
SELL
18 May 2020
Thomsen Jillian B.
SVP & Chief Accounting Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
172,719
-0%
1,367
$22.51
$30,771.17
SELL
18 May 2020
Zalevsky Jonathan
Chief R&D Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
322,515
-1%
4,558
$22.51
$102,600.58
SELL
18 May 2020
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
375,903
-2%
8,968
$22.51
$201,869.69
SELL
15 Apr 2020
CHESS ROBERT
Director
NEKTAR THERAPEUTICS
(NKTR)
277,170
-2%
8,000
$18.38
$147,010.02
SELL
11 Mar 2020
CHESS ROBERT
Director
NEKTAR THERAPEUTICS
(NKTR)
278,173
-2%
8,000
$16.79
$134,316.00
SELL
18 Feb 2020
Labrucherie Gil M
SVP, COO & CFO, Officer
NEKTAR THERAPEUTICS
(NKTR)
253,221
-2%
5,938
$22.35
$132,714.30
SELL
18 Feb 2020
Thomsen Jillian B.
SVP & Chief Accounting Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
174,086
-0%
1,394
$22.35
$31,155.90
SELL
18 Feb 2020
Zalevsky Jonathan
Chief R&D Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
327,073
-1%
4,774
$22.35
$106,698.90
SELL
18 Feb 2020
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
384,871
-2%
8,448
$22.35
$188,812.80
SELL
12 Feb 2020
CHESS ROBERT
Director
NEKTAR THERAPEUTICS
(NKTR)
280,572
-2%
8,000
$23.50
$187,999.60
SELL
6 Feb 2020
Thomsen Jillian B.
SVP & Chief Accounting Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
175,480
-17%
37,500
$22.78
$854,250.00
SELL
18 Nov 2019
Labrucherie Gil M
SVP, COO & CFO, Officer
NEKTAR THERAPEUTICS
(NKTR)
219,009
-3%
8,863
$17.97
$159,268.11
SELL
18 Nov 2019
Thomsen Jillian B.
SVP & Chief Accounting Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
160,441
-1%
2,713
$17.97
$48,752.61
SELL
18 Nov 2019
Zalevsky Jonathan
Chief R&D Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
291,697
-1%
3,960
$17.97
$71,161.20
SELL
18 Nov 2019
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
299,219
-4%
13,556
$17.97
$243,601.31
SELL
13 Nov 2019
Labrucherie Gil M
SVP, COO & CFO, Officer
NEKTAR THERAPEUTICS
(NKTR)
227,872
-9%
25,000
$19.79
$494,750.03
SELL
15 Oct 2019
Labrucherie Gil M
SVP, COO & CFO, Officer
NEKTAR THERAPEUTICS
(NKTR)
227,872
-9%
25,000
$15.83
$395,750.00
SELL
15 Oct 2019
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
312,775
-24%
100,000
$17.37
$1,737,090.20
SELL
30 Sep 2019
Ajer Jeffrey Robert
Director
NEKTAR THERAPEUTICS
(NKTR)
22,375
-9%
2,375
$18.06
$42,892.50
SELL
27 Sep 2019
Lingnau Lutz
Director
NEKTAR THERAPEUTICS
(NKTR)
26,700
-10%
3,000
$17.84
$53,520.00
SELL
27 Sep 2019
CHESS ROBERT
Director
NEKTAR THERAPEUTICS
(NKTR)
276,973
-1%
4,000
$17.99
$71,960.00
SELL
20 Sep 2019
Ajer Jeffrey Robert
Director
NEKTAR THERAPEUTICS
(NKTR)
18,250
-10%
2,250
$20.24
$45,540.00
SELL
16 Sep 2019
Labrucherie Gil M
SVP & Chief Financial Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
152,872
-14%
25,000
$20.52
$513,000.00
BUY
5 Sep 2019
Doberstein Stephen K
SVP & Chief Scientific Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
107,668
+16%
15,000
$17.28
$259,200.02
SELL
16 Aug 2019
Doberstein Stephen K
SVP & Chief Scientific Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
92,668
-3%
3,245
$18.15
$58,896.75
SELL
16 Aug 2019
Nicholson John
SVP & Chief Operating Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
162,759
-2%
3,819
$18.15
$69,314.85
SELL
16 Aug 2019
Labrucherie Gil M
SVP & Chief Financial Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
122,872
-3%
5,063
$18.15
$91,893.45
SELL
16 Aug 2019
Thomsen Jillian B.
SVP & Chief Accounting Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
163,154
-1%
1,809
$18.15
$32,833.35
SELL
16 Aug 2019
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
282,775
-4%
12,551
$18.15
$227,800.64
SELL
14 Aug 2019
Labrucherie Gil M
SVP & Chief Financial Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
127,935
-16%
25,000
$17.79
$444,750.03
SELL
23 Jul 2019
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
295,326
-25%
100,000
$31.29
$3,128,667.50
SELL
10 Jul 2019
Labrucherie Gil M
SVP & Chief Financial Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
127,935
-16%
25,000
$34.57
$864,250.00
SELL
8 Jul 2019
Lingnau Lutz
Director
NEKTAR THERAPEUTICS
(NKTR)
23,200
-30%
10,000
$34.63
$346,300.00
SELL
17 Jun 2019
Labrucherie Gil M
SVP & Chief Financial Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
127,935
-16%
25,000
$33.71
$842,750.00
SELL
21 May 2019
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
295,326
-25%
100,000
$33.00
$3,300,000.50
SELL
16 May 2019
Doberstein Stephen K
SVP & Chief Scientific Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
95,913
-3%
3,461
$31.37
$108,571.57
SELL
16 May 2019
Nicholson John
SVP & Chief Operating Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
166,578
-2%
4,077
$31.37
$127,895.49
SELL
16 May 2019
Hora Maninder
SVP Pharma Dev & Mfg Ops, Officer
NEKTAR THERAPEUTICS
(NKTR)
94,694
-2%
2,449
$31.37
$76,825.13
SELL
16 May 2019
Labrucherie Gil M
SVP & Chief Financial Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
127,935
-2%
3,767
$31.37
$118,170.80
SELL
16 May 2019
Thomsen Jillian B.
SVP & Chief Accounting Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
164,463
-1%
1,928
$31.37
$60,481.36
SELL
16 May 2019
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
295,326
-4%
13,383
$31.37
$419,824.72
SELL
19 Feb 2019
Doberstein Stephen K
SVP & Chief Scientific Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
99,374
-3%
3,310
$42.39
$140,310.89
SELL
19 Feb 2019
Nicholson John
SVP & Chief Operating Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
170,655
-2%
3,822
$42.39
$162,014.58
SELL
19 Feb 2019
Hora Maninder
SVP Pharma Dev & Mfg Ops, Officer
NEKTAR THERAPEUTICS
(NKTR)
97,143
-2%
2,386
$42.39
$101,142.54
SELL
19 Feb 2019
Labrucherie Gil M
SVP & Chief Financial Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
131,702
-2%
3,592
$42.39
$152,264.88
SELL
19 Feb 2019
Thomsen Jillian B.
SVP & Chief Accounting Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
166,391
-1%
1,808
$42.39
$76,641.12
SELL
19 Feb 2019
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
308,709
-26%
108,882
$42.19
$4,594,176.00
SELL
4 Feb 2019
Thomsen Jillian B.
SVP & Chief Accounting Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
168,199
-8%
16,119
$42.16
$679,577.06
SELL
28 Jan 2019
Nicholson John
SVP & Chief Operating Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
174,477
-26%
63,000
$42.82
$2,697,660.00
SELL
16 Nov 2018
Doberstein Stephen K
SVP & Chief Scientific Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
78,734
-5%
4,524
$38.25
$173,043.00
SELL
16 Nov 2018
Nicholson John
SVP & Chief Operating Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
174,477
-3%
5,982
$38.25
$228,811.50
SELL
16 Nov 2018
Hora Maninder
SVP Pharma Dev & Mfg Ops, Officer
NEKTAR THERAPEUTICS
(NKTR)
81,029
-5%
4,694
$38.25
$179,545.50
SELL
16 Nov 2018
Labrucherie Gil M
SVP & Chief Financial Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
106,544
-5%
6,515
$38.25
$249,198.75
SELL
16 Nov 2018
Thomsen Jillian B.
SVP & Chief Accounting Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
157,249
-2%
4,016
$38.25
$153,612.00
SELL
16 Nov 2018
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
249,141
-5%
15,326
$38.25
$586,219.50
SELL
20 Sep 2018
Lingnau Lutz
Director
NEKTAR THERAPEUTICS
(NKTR)
18,450
-32%
9,000
$56.98
$512,820.00
SELL
20 Sep 2018
Ajer Jeffrey Robert
Director
NEKTAR THERAPEUTICS
(NKTR)
15,750
-30%
6,750
$56.76
$383,130.00
SELL
19 Sep 2018
CHESS ROBERT
Director
NEKTAR THERAPEUTICS
(NKTR)
269,723
-1%
4,500
$56.81
$255,645.00
SELL
4 Sep 2018
GREER R SCOTT
Director
NEKTAR THERAPEUTICS
(NKTR)
130,333
-7%
10,000
$67.39
$673,900.00
SELL
17 Aug 2018
WINGER DENNIS L
Director
NEKTAR THERAPEUTICS
(NKTR)
42,750
-41%
30,000
$59.96
$1,798,800.00
SELL
13 Aug 2018
WINGER DENNIS L
Director
NEKTAR THERAPEUTICS
(NKTR)
42,750
-44%
34,250
$60.60
$2,075,378.80
SELL
25 Jun 2018
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
224,356
-36%
130,000
$49.52
$6,438,036.00
SELL
21 Jun 2018
Josh Gottheimer
Congressman (House)
NEKTAR THERAPEUTICS
(NKTR)
N/A
N/A
N/A
$1,001 - $15,000
BUY
6 Jun 2018
Josh Gottheimer
Congressman (House)
NEKTAR THERAPEUTICS
(NKTR)
N/A
N/A
N/A
$1,001 - $15,000
BUY
5 Jun 2018
WHITFIELD ROY A
Director
NEKTAR THERAPEUTICS
(NKTR)
175,600
+2%
5,000
$58.04
$290,212.00
SELL
5 Jun 2018
CHESS ROBERT
Director
NEKTAR THERAPEUTICS
(NKTR)
274,223
-3%
10,000
$55.16
$551,600.00
SELL
4 Jun 2018
GREER R SCOTT
Director
NEKTAR THERAPEUTICS
(NKTR)
130,333
-7%
10,000
$60.28
$602,786.00
SELL
16 May 2018
Doberstein Stephen K
SVP & Chief Scientific Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
63,959
-5%
3,435
$83.39
$286,444.66
SELL
16 May 2018
Nicholson John
SVP & Chief Operating Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
162,596
-2%
4,917
$83.39
$410,028.62
SELL
16 May 2018
Hora Maninder
SVP Pharma Dev & Mfg Ops, Officer
NEKTAR THERAPEUTICS
(NKTR)
76,201
-5%
4,060
$83.39
$338,563.40
SELL
16 May 2018
Labrucherie Gil M
SVP & Chief Financial Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
94,798
-4%
4,941
$83.39
$412,030.00
SELL
16 May 2018
Thomsen Jillian B.
SVP & Chief Accounting Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
65,281
-5%
3,576
$83.39
$298,202.62
SELL
16 May 2018
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
224,356
-5%
12,791
$83.39
$1,066,641.50
SELL
3 May 2018
CHESS ROBERT
Director
NEKTAR THERAPEUTICS
(NKTR)
274,223
-8%
25,000
$82.80
$2,070,050.00
SELL
1 May 2018
Labrucherie Gil M
SVP & Chief Financial Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
99,739
-47%
90,000
$84.05
$7,564,200.00
SELL
1 May 2018
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
237,147
-35%
130,000
$84.05
$10,926,066.00
SELL
16 Apr 2018
Thomsen Jillian B.
SVP & Chief Accounting Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
68,857
-16%
13,881
$101.46
$1,408,366.20
SELL
10 Apr 2018
Hora Maninder
SVP Pharma Dev & Mfg Ops, Officer
NEKTAR THERAPEUTICS
(NKTR)
80,261
-0%
502
$105.67
$53,046.34
SELL
6 Apr 2018
Doberstein Stephen K
SVP & Chief Scientific Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
67,394
-70%
160,000
$93.06
$14,890,180.00
SELL
6 Apr 2018
GREER R SCOTT
Director
NEKTAR THERAPEUTICS
(NKTR)
130,333
-18%
30,000
$92.22
$2,766,600.00
SELL
6 Apr 2018
CHESS ROBERT
Director
NEKTAR THERAPEUTICS
(NKTR)
274,223
-8%
25,000
$92.14
$2,303,600.00
SELL
5 Apr 2018
Lingnau Lutz
Director
NEKTAR THERAPEUTICS
(NKTR)
27,450
-52%
30,000
$101.74
$3,052,200.00
SELL
5 Apr 2018
Hora Maninder
SVP Pharma Dev & Mfg Ops, Officer
NEKTAR THERAPEUTICS
(NKTR)
80,261
-26%
29,498
$102.81
$3,032,765.00
SELL
6 Mar 2018
KUEBLER CHRISTOPHER A
Director
NEKTAR THERAPEUTICS
(NKTR)
40,500
-49%
40,000
$97.60
$3,903,914.20
SELL
6 Mar 2018
Nicholson John
SVP & Chief Operating Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
167,513
-56%
220,144
$99.27
$21,854,264.00
SELL
16 Feb 2018
Doberstein Stephen K
SVP & Chief Scientific Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
67,394
-3%
2,426
$82.94
$201,212.45
SELL
16 Feb 2018
Nicholson John
SVP & Chief Operating Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
387,657
-1%
4,879
$82.94
$404,664.28
SELL
16 Feb 2018
Hora Maninder
SVP Pharma Dev & Mfg Ops, Officer
NEKTAR THERAPEUTICS
(NKTR)
80,261
-3%
2,875
$82.94
$238,452.50
SELL
16 Feb 2018
Labrucherie Gil M
SVP & Chief Financial Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
99,739
-3%
3,477
$82.94
$288,382.38
SELL
16 Feb 2018
Thomsen Jillian B.
SVP & Chief Accounting Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
68,857
-3%
2,545
$82.94
$211,082.31
SELL
16 Feb 2018
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
237,147
-5%
12,788
$82.94
$1,060,636.80
SELL
22 Jan 2018
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
249,935
-25%
83,333
$75.82
$6,318,308.00
SELL
2 Jan 2018
KUEBLER CHRISTOPHER A
Director
NEKTAR THERAPEUTICS
(NKTR)
40,500
-42%
30,000
$58.66
$1,759,800.00
SELL
13 Dec 2017
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
189,435
-30%
83,333
$55.69
$4,640,814.50
SELL
13 Nov 2017
Nicholson John
SVP & Chief Operating Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
233,156
-6%
15,910
$37.78
$601,079.75
SELL
6 Nov 2017
Doberstein Stephen K
SVP & Chief Scientific Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
31,102
-92%
396,323
$29.00
$11,493,476.00
SELL
6 Nov 2017
Hora Maninder
SVP Pharma Dev & Mfg Ops, Officer
NEKTAR THERAPEUTICS
(NKTR)
58,233
-8%
5,117
$25.07
$128,283.19
SELL
1 Nov 2017
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
152,504
-35%
83,334
$23.57
$1,964,182.40
SELL
9 Oct 2017
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
152,504
-35%
83,333
$24.20
$2,016,658.60
SELL
5 Oct 2017
Doberstein Stephen K
SVP & Chief Scientific Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
31,102
-58%
43,677
$24.97
$1,090,614.60
SELL
5 Oct 2017
Hora Maninder
SVP Pharma Dev & Mfg Ops, Officer
NEKTAR THERAPEUTICS
(NKTR)
58,233
-11%
7,583
$25.00
$189,575.00
SELL
2 Oct 2017
Labrucherie Gil M
SVP & Chief Financial Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
63,414
-65%
120,000
$24.45
$2,934,000.00
SELL
29 Sep 2017
Gergel Ivan P.
SVP & Chief Medical Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
41,575
-70%
100,000
$24.14
$2,413,639.50
SELL
22 Sep 2017
KUEBLER CHRISTOPHER A
Director
NEKTAR THERAPEUTICS
(NKTR)
40,500
-8%
4,000
$21.86
$87,440.00
SELL
22 Sep 2017
Lingnau Lutz
Director
NEKTAR THERAPEUTICS
(NKTR)
27,450
-15%
5,000
$21.97
$109,850.00
SELL
21 Sep 2017
CHESS ROBERT
Director
NEKTAR THERAPEUTICS
(NKTR)
274,223
-2%
6,400
$21.72
$139,008.00
SELL
6 Sep 2017
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
152,504
-35%
83,333
$21.54
$1,794,992.90
SELL
16 Aug 2017
Doberstein Stephen K
SVP & Chief Scientific Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
31,102
-5%
1,701
$19.32
$32,863.32
SELL
16 Aug 2017
Nicholson John
SVP & Chief Operating Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
224,066
-1%
3,177
$19.32
$61,379.64
SELL
16 Aug 2017
Hora Maninder
SVP Pharma Dev & Mfg Ops, Officer
NEKTAR THERAPEUTICS
(NKTR)
58,233
-4%
2,956
$19.32
$57,109.92
SELL
16 Aug 2017
Labrucherie Gil M
SVP & Chief Financial Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
63,414
-4%
3,177
$19.32
$61,379.64
SELL
16 Aug 2017
Gergel Ivan P.
SVP & Chief Medical Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
41,575
-4%
1,997
$19.32
$38,582.04
SELL
16 Aug 2017
Thomsen Jillian B.
SVP & Chief Accounting Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
50,838
-4%
2,648
$19.32
$51,159.36
SELL
16 Aug 2017
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
152,504
-37%
91,714
$19.26
$1,766,081.10
BUY
10 Aug 2017
WHITFIELD ROY A
Director
NEKTAR THERAPEUTICS
(NKTR)
133,000
+35%
35,000
$17.95
$628,250.00
SELL
18 Jul 2017
Gergel Ivan P.
SVP & Chief Medical Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
43,572
-55%
54,920
$21.10
$1,158,812.00
SELL
14 Jul 2017
Lingnau Lutz
Director
NEKTAR THERAPEUTICS
(NKTR)
23,450
-56%
30,000
$20.76
$622,800.00
SELL
11 Jul 2017
Gergel Ivan P.
SVP & Chief Medical Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
43,572
-50%
45,080
$21.08
$950,317.75
SELL
7 Jun 2017
Nicholson John
SVP & Chief Operating Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
227,243
-30%
101,700
$19.24
$1,956,708.00
SELL
16 May 2017
Doberstein Stephen K
SVP & Chief Scientific Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
32,803
-4%
1,701
$19.55
$33,254.55
SELL
16 May 2017
Nicholson John
SVP & Chief Operating Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
178,943
-1%
3,146
$19.55
$61,504.30
SELL
16 May 2017
Hora Maninder
SVP Pharma Dev & Mfg Ops, Officer
NEKTAR THERAPEUTICS
(NKTR)
60,689
-4%
2,959
$19.55
$57,848.45
SELL
16 May 2017
Labrucherie Gil M
SVP & Chief Financial Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
66,091
-4%
3,179
$19.55
$62,149.45
SELL
16 May 2017
Gergel Ivan P.
SVP & Chief Medical Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
43,572
-3%
1,450
$19.55
$28,347.50
SELL
16 May 2017
Thomsen Jillian B.
SVP & Chief Accounting Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
52,986
-4%
2,651
$19.55
$51,827.05
SELL
16 May 2017
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
160,884
-4%
8,388
$19.55
$163,985.39
SELL
15 May 2017
CHESS ROBERT
Director
NEKTAR THERAPEUTICS
(NKTR)
271,623
-1%
5,000
$19.79
$98,950.01
SELL
17 Apr 2017
CHESS ROBERT
Director
NEKTAR THERAPEUTICS
(NKTR)
271,623
-1%
5,000
$18.72
$93,600.00
SELL
7 Apr 2017
Lingnau Lutz
Director
NEKTAR THERAPEUTICS
(NKTR)
23,450
-22%
7,000
$20.05
$140,350.00
SELL
5 Apr 2017
KUEBLER CHRISTOPHER A
Director
NEKTAR THERAPEUTICS
(NKTR)
35,500
-29%
15,000
$21.88
$328,200.00
SELL
5 Apr 2017
Doberstein Stephen K
SVP & Chief Scientific Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
34,504
-74%
100,000
$21.70
$2,170,000.00
SELL
5 Apr 2017
Hora Maninder
SVP Pharma Dev & Mfg Ops, Officer
NEKTAR THERAPEUTICS
(NKTR)
63,648
-73%
180,000
$21.70
$3,906,000.20
SELL
20 Mar 2017
Thomsen Jillian B.
SVP & Chief Accounting Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
55,637
-66%
112,500
$19.69
$2,215,125.00
SELL
14 Mar 2017
CHESS ROBERT
Director
NEKTAR THERAPEUTICS
(NKTR)
271,623
-1%
5,000
$15.41
$77,050.00
SELL
2 Mar 2017
Labrucherie Gil M
SVP & Chief Financial Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
69,270
-74%
200,000
$15.16
$3,031,949.50
SELL
21 Feb 2017
Lingnau Lutz
Director
NEKTAR THERAPEUTICS
(NKTR)
30,450
-49%
30,000
$13.08
$392,400.00
SELL
16 Feb 2017
Doberstein Stephen K
SVP & Chief Scientific Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
34,504
-3%
1,261
$13.14
$16,569.54
SELL
16 Feb 2017
Nicholson John
SVP & Chief Operating Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
182,089
-1%
3,237
$13.14
$42,534.18
SELL
16 Feb 2017
Hora Maninder
SVP Pharma Dev & Mfg Ops, Officer
NEKTAR THERAPEUTICS
(NKTR)
63,648
-3%
2,195
$13.14
$28,842.30
SELL
16 Feb 2017
Labrucherie Gil M
SVP & Chief Financial Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
69,270
-3%
2,359
$13.14
$30,997.26
SELL
16 Feb 2017
Gergel Ivan P.
SVP & Chief Medical Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
45,022
-3%
1,457
$13.14
$19,144.98
SELL
16 Feb 2017
Thomsen Jillian B.
SVP & Chief Accounting Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
55,637
-3%
1,965
$13.14
$25,820.10
SELL
16 Feb 2017
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
169,272
-4%
8,636
$13.14
$113,477.04
SELL
8 Feb 2017
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
177,908
-32%
87,500
$13.04
$1,141,000.00
SELL
2 Feb 2017
Nicholson John
SVP & Chief Operating Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
140,326
-34%
75,000
$12.39
$929,350.50
SELL
17 Jan 2017
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
177,908
-32%
87,500
$12.35
$1,080,625.00
SELL
7 Dec 2016
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
122,908
-41%
87,500
$12.24
$1,071,000.00
SELL
16 Nov 2016
Doberstein Stephen K
SVP & Chief Scientific Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
18,265
-3%
670
$13.96
$9,353.20
SELL
16 Nov 2016
Nicholson John
SVP & Chief Operating Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
120,326
-1%
1,654
$13.96
$23,089.84
SELL
16 Nov 2016
Hora Maninder
SVP Pharma Dev & Mfg Ops, Officer
NEKTAR THERAPEUTICS
(NKTR)
50,343
-3%
1,654
$13.96
$23,089.84
SELL
16 Nov 2016
Labrucherie Gil M
SVP & Chief Financial Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
51,129
-3%
1,654
$13.96
$23,089.84
SELL
16 Nov 2016
Gergel Ivan P.
SVP & Chief Medical Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
26,479
-3%
848
$13.96
$11,838.08
SELL
16 Nov 2016
Thomsen Jillian B.
SVP & Chief Accounting Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
42,102
-4%
1,986
$13.96
$27,724.56
SELL
16 Nov 2016
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
122,908
-43%
93,458
$13.88
$1,296,798.60
BUY
24 Oct 2016
GREER R SCOTT
Director
NEKTAR THERAPEUTICS
(NKTR)
121,333
+14%
15,000
$13.50
$202,500.00
SELL
4 Oct 2016
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
128,866
-40%
87,500
$17.06
$1,492,750.00
SELL
15 Sep 2016
KUEBLER CHRISTOPHER A
Director
NEKTAR THERAPEUTICS
(NKTR)
27,500
-21%
7,500
$19.13
$143,475.00
SELL
15 Sep 2016
Lingnau Lutz
Director
NEKTAR THERAPEUTICS
(NKTR)
7,450
-54%
9,000
$19.06
$171,540.00
SELL
15 Sep 2016
CHESS ROBERT
Director
NEKTAR THERAPEUTICS
(NKTR)
248,623
-4%
12,000
$19.21
$230,519.98
SELL
1 Sep 2016
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
128,886
-40%
87,500
$17.83
$1,560,125.00
SELL
16 Aug 2016
Doberstein Stephen K
SVP & Chief Scientific Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
18,935
-6%
1,336
$17.56
$23,460.16
SELL
16 Aug 2016
Nicholson John
SVP & Chief Operating Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
121,980
-2%
3,317
$17.56
$58,246.52
SELL
16 Aug 2016
Hora Maninder
SVP Pharma Dev & Mfg Ops, Officer
NEKTAR THERAPEUTICS
(NKTR)
51,997
-5%
3,305
$17.56
$58,035.80
SELL
16 Aug 2016
Labrucherie Gil M
SVP & Chief Financial Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
52,783
-5%
3,305
$17.56
$58,035.80
SELL
16 Aug 2016
Gergel Ivan P.
SVP & Chief Medical Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
27,327
-5%
1,685
$17.56
$29,588.60
SELL
16 Aug 2016
Thomsen Jillian B.
SVP & Chief Accounting Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
44,088
-8%
3,971
$17.56
$69,730.76
SELL
16 Aug 2016
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
128,866
-8%
11,817
$17.56
$207,506.52
SELL
1 Aug 2016
CHESS ROBERT
Director
NEKTAR THERAPEUTICS
(NKTR)
260,623
-1%
5,000
$17.26
$86,300.00
SELL
11 Jul 2016
Thomsen Jillian B.
SVP & Chief Accounting Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
6,809
-93%
100,000
$15.09
$1,509,000.00
SELL
1 Jul 2016
CHESS ROBERT
Director
NEKTAR THERAPEUTICS
(NKTR)
260,623
-1%
5,000
$14.10
$70,500.00
SELL
1 Jun 2016
CHESS ROBERT
Director
NEKTAR THERAPEUTICS
(NKTR)
260,623
-1%
5,000
$15.50
$77,500.00
SELL
16 May 2016
Doberstein Stephen K
SVP & Chief Scientific Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
1,021
-24%
339
$13.58
$4,603.62
SELL
16 May 2016
Nicholson John
SVP & Chief Financial Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
77,630
-1%
856
$13.58
$11,624.48
SELL
16 May 2016
Hora Maninder
SVP Pharma Dev & Mfg Ops, Officer
NEKTAR THERAPEUTICS
(NKTR)
7,135
-10%
835
$13.58
$11,339.30
SELL
16 May 2016
Labrucherie Gil M
SVP & General Counsel, Officer
NEKTAR THERAPEUTICS
(NKTR)
7,921
-9%
836
$13.58
$11,352.88
SELL
16 May 2016
Gergel Ivan P.
SVP & Chief Medical Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
1,512
-22%
432
$13.58
$5,866.56
SELL
16 May 2016
Thomsen Jillian B.
SVP & Chief Accounting Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
6,309
-10%
724
$13.58
$9,831.92
SELL
16 May 2016
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
16,933
-11%
2,170
$13.58
$29,468.60
SELL
25 Apr 2016
Lingnau Lutz
Director
NEKTAR THERAPEUTICS
(NKTR)
16,450
-47%
15,000
$16.27
$244,050.00
SELL
9 Mar 2016
Thomsen Jillian B.
SVP & Chief Accounting Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
5,158
-74%
15,000
$11.79
$176,850.00
SELL
16 Feb 2016
Doberstein Stephen K
SVP & Chief Scientific Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
485
-44%
390
$11.92
$4,648.80
SELL
16 Feb 2016
Nicholson John
SVP & Chief Financial Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
76,319
-1%
963
$11.92
$11,478.96
SELL
16 Feb 2016
Hora Maninder
SVP Pharma Dev & Mfg Ops, Officer
NEKTAR THERAPEUTICS
(NKTR)
5,803
-14%
963
$11.92
$11,478.96
SELL
16 Feb 2016
Labrucherie Gil M
SVP & General Counsel, Officer
NEKTAR THERAPEUTICS
(NKTR)
6,590
-11%
827
$11.92
$9,857.84
SELL
16 Feb 2016
Gergel Ivan P.
SVP & Chief Medical Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
694
-44%
556
$11.92
$6,627.52
SELL
16 Feb 2016
Thomsen Jillian B.
SVP & Chief Accounting Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
5,158
-12%
716
$11.92
$8,534.72
SELL
16 Feb 2016
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
13,478
-13%
2,147
$11.92
$25,592.24
SELL
10 Feb 2016
Labrucherie Gil M
SVP & General Counsel, Officer
NEKTAR THERAPEUTICS
(NKTR)
5,251
-68%
11,666
$11.49
$134,042.34
SELL
10 Feb 2016
Thomsen Jillian B.
SVP & Chief Accounting Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
3,999
-78%
15,000
$11.49
$172,350.00
SELL
10 Feb 2016
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
10,000
-86%
66,666
$11.49
$765,992.30
SELL
20 Jan 2016
Lingnau Lutz
Director
NEKTAR THERAPEUTICS
(NKTR)
16,450
-47%
15,000
$14.51
$217,650.00
SELL
19 Jan 2016
Labrucherie Gil M
SVP & General Counsel, Officer
NEKTAR THERAPEUTICS
(NKTR)
5,251
-68%
11,667
$14.12
$164,738.03
SELL
19 Jan 2016
Thomsen Jillian B.
SVP & Chief Accounting Officer, Officer
NEKTAR THERAPEUTICS
(NKTR)
3,999
-78%
15,000
$14.12
$211,800.00
SELL
19 Jan 2016
ROBIN HOWARD W
President & CEO, Director, Officer
NEKTAR THERAPEUTICS
(NKTR)
10,000
-86%
66,667
$14.12
$941,338.06
Home